Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
<< Back to Results
This randomized phase II trial is studying the side effects and how well giving cetuximab and irinotecan hydrochloride with or without ramucirumab work in treating patients with advanced colorectal cancer with progressive disease after treatment with bevacizumab-containing chemotherapy.
Essentia Health Brainerd, Essentia Health Duluth, Essentia Health Fargo
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.